Austen Slade, MD
Urology · Indianapolis, INNPI 1467815530
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 40.4% of the total. 2025 is the largest year on record at $41,085, more than ten times the $831 reported in 2019. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $282.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$30K
- Cook Incorporated$19K
- Richard Wolf Medical Instruments Corp.$11K
- Hologic Sales And Service, LLC$7K
- Cook Medical LLC$2K
- Laborie Medical Technologies Corp.$2K
- plus $3K from 18 others
What the payments were for
- Consulting fees$16,86323%
- Speaking & faculty fees$42,06657%
- Travel & lodging$3,5045%
- Food & beverage$10,94715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 165 | $29,611 |
| Cook Incorporated | 12 | $19,026 |
| Richard Wolf Medical Instruments Corp. | 16 | $11,421 |
| Hologic Sales And Service, LLC | 6 | $6,637 |
| Cook Medical LLC | 16 | $1,663 |
| Laborie Medical Technologies Corp. | 7 | $1,628 |
| Cytyc Surgical Products, LLC | 9 | $1,625 |
| Coloplast | 7 | $601 |
| Dornier Medtech America, Inc | 1 | $352 |
| Endo Pharmaceuticals Inc. | 1 | $122 |
| Biocompatibles, Inc. | 1 | $107 |
| Procept Biorobotics Corporation | 3 | $96 |
| AbbVie | 3 | $80 |
| SRS Medical Systems, Inc. | 1 | $79 |
| Astellas Pharma US Inc | 2 | $68 |
| Sumitomo Pharma America, Inc. | 1 | $58 |
| Ambu Inc. | 2 | $37 |
| Stryker | 1 | $31 |
| Progenics Pharmaceuticals, Inc. | 1 | $30 |
| Tempus AI, Inc | 1 | $30 |
| Calyxo, Inc. | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$22,774
- LITHO 150$9,186
- Cook$6,975
- MYOSURE TISSUE REMOVAL DEVICE$6,496
- NONE$1,376
- Optilume BPH Drug Coated Balloon Catheter$1,253
- GENERAL - THERAPIES$877
- S~Curve$519
- LithoVue$511
- Dornier MedTech$352
- TITAN$291
- ACESSA PROVU SYSTEM$255
- Porges Coloplast$143
- GENERAL KIDNEY STONE DISEASE$139
- RESONANCE$139
- XIAFLEX$122
- SWISS LITHOCLAST TRILOGY$115
- Moses 550 DFL$110
- VISUAL-ICE$107
- CoolSeal Generator$106
How this compares
$73,381 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 20 | $9,773 |
| Trospium Chloride | 35 | $1,994 |
| Tamsulosin Hcl | 125 | $1,069 |
| Potassium Citrate ErPotassium Citrate | 14 | $882 |
| Celecoxib | 30 | $643 |
| Methenamine Hippurate | 13 | $527 |
| Testosterone Cypionate | 12 | $513 |
| Finasteride | 39 | $325 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 15 | $308 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $304 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 58 | $186 |
| Ciprofloxacin Hcl | 25 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $68 | $9,77320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 272 urology providers in Indiana.
Other urology in Indianapolis
- Michael BorofskyIndianapolis$244K
- Marcelino RiveraIndianapolis$171K
- Helen BernieIndianapolis$100K
- Jacob RustIndianapolis$57K
- Alvin WeeIndianapolis$46K
- Jason SprungerIndianapolis$30K
- Steven KheyfetsIndianapolis$18K
- Hristos KaimakliotisIndianapolis$12K
- Adri DurantIndianapolis$12K
- Thairo PereiraIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.